Kazia Therapeutics(KZIA) - 2025 Q2 - Quarterly Report

Exhibit 99.1 Chairman and CEO's Letter 8 Exhibit 99.1 2024 ANNUAL REPORT Contents 2 Environment, Society & Governance The journey of a young biotech company is often circuitous, but we have nevertheless continued to make great progress in the past year. We have two first-class drug candidates in clinical development, with a diverse portfolio of trials that have the potential to open up very substantial commercial markets. We have an experienced and capable team, and an international network of supportive pa ...